...
首页> 外文期刊>microsystems & nanoengineering >Measurement of oxygen consumption rates of human renal proximal tubule cells in an array of organ-on-chip devices to monitor drug-induced metabolic shifts
【24h】

Measurement of oxygen consumption rates of human renal proximal tubule cells in an array of organ-on-chip devices to monitor drug-induced metabolic shifts

机译:在一系列器官芯片设备中测量人肾近端肾小管细胞的耗氧率,以监测药物诱导的代谢变化

获取原文
获取原文并翻译 | 示例

摘要

Measurement of cell metabolism in moderate-throughput to high-throughput organ-on-chip (OOC) systems would expand the range of data collected for studying drug effects or disease in physiologically relevant tissue models. However, current measurement approaches rely on fluorescent imaging or colorimetric assays that are focused on endpoints, require labels or added substrates, and lack real-time data. Here, we integrated optical-based oxygen sensors in a high-throughput OOC platform and developed an approach for monitoring cell metabolic activity in an array of membrane bilayer devices. Each membrane bilayer device supported a culture of human renal proximal tubule epithelial cells on a porous membrane suspended between two microchannels and exposed to controlled, unidirectional perfusion and physiologically relevant shear stress for several days. For the first time, we measured changes in oxygen in a membrane bilayer format and used a finite element analysis model to estimate cell oxygen consumption rates (OCRs), allowing comparison with OCRs from other cell culture systems. Finally, we demonstrated label-free detection of metabolic shifts in human renal proximal tubule cells following exposure to FCCP, a drug known for increasing cell oxygen consumption, as well as oligomycin and antimycin A, drugs known for decreasing cell oxygen consumption. The capability to measure cell OCRs and detect metabolic shifts in an array of membrane bilayer devices contained within an industry standard microtiter plate format will be valuable for analyzing flow-responsive and physiologically complex tissues during drug development and disease research.
机译:在中通量到高通量器官芯片(OOC)系统中测量细胞代谢将扩大收集的数据范围,用于研究生理相关组织模型中的药物效应或疾病。然而,目前的测量方法依赖于荧光成像或比色分析,这些方法专注于终点,需要标记或添加底物,并且缺乏实时数据。在这里,我们将基于光学的氧传感器集成到高通量OOC平台中,并开发了一种在一系列膜双层装置中监测细胞代谢活性的方法。每个膜双层装置都支持在悬浮在两个微通道之间的多孔膜上培养人肾近端肾小管上皮细胞,并暴露于受控的单向灌注和生理相关的剪切应力数天。我们首次测量了膜双层形式的氧气变化,并使用有限元分析模型来估计细胞耗氧率 (OCR),从而可以与其他细胞培养系统的 OCR 进行比较。最后,我们证明了暴露于FCCP(一种已知增加细胞耗氧量的药物)以及寡霉素和抗霉素A(已知用于减少细胞耗氧量的药物)后,对人肾近端肾小管细胞代谢变化的无标记检测。在药物开发和疾病研究期间,测量细胞 OCR 并检测包含在行业标准微量滴定板格式中的膜双层装置阵列中的代谢变化的能力对于分析流动响应和生理复杂组织非常有价值。

著录项

相似文献

  • 外文文献
  • 中文文献
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号